Literature DB >> 30863597

Radical surgical resection after neoadjuvant targeted therapy in non-small cell lung cancer: a single-center retrospective study of 6 cases.

Zhenyang Zhang1, Jiangbo Lin1, Shuai Peng1, Wenwei Lin1, Mingqiang Kang1.   

Abstract

Entities:  

Year:  2019        PMID： 30863597      PMCID： PMC6384356          DOI： 10.21037/jtd.2018.12.97

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

1.  Surgical resection of lung adenocarcinoma without EGFR mutation after neoadjuvant gefitinib treatment.

Authors:  Hong Shen; Xian Zhong; Xiao-Qin Ge; Jian-Jin Huang; Ying Yuan
Journal:  Clin Respir J       Date:  2010-07       Impact factor: 2.570

2.  A new concept of endoscopic lung cancer resection: Single-direction thoracoscopic lobectomy.

Authors:  Lunxu Liu; Guowei Che; Qiang Pu; Lin Ma; Yigen Wu; Qiwei Kan; Xuepeng Zhuge; Lu Shi
Journal:  Surg Oncol       Date:  2009-06-04       Impact factor: 3.279

3.  Surgical resection of locally advanced pulmonary adenocarcinoma after gefitinib therapy.

Authors:  Ming Liu; Gening Jiang; Wenxin He; Peng Zhang; Nan Song
Journal:  Ann Thorac Surg       Date:  2011-07       Impact factor: 4.330

4.  Long-term outcome of surgical resection for residual or regrown advanced non-small cell lung carcinomas following EGFR-TKI treatment: report of four cases.

Authors:  Tomoyuki Hishida; Junji Yoshida; Keiju Aokage; Kanji Nagai; Masahiro Tsuboi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-12-16

5.  Adenosquamous cell lung cancer successfully treated with gefitinib: A case report.

Authors:  Koichi Kurishima; Gen Ohara; Katsunori Kagohashi; Hiroko Watanabe; Norio Takayashiki; Atsushi Ishibashi; Hiroaki Satoh
Journal:  Mol Clin Oncol       Date:  2013-12-09

6.  Surgical resection after gefitinib treatment in patients with lung adenocarcinoma harboring epidermal growth factor receptor gene mutation.

Authors:  Kazuya Takamochi; Kazuya Suzuki; Haruhiko Sugimura; Kazuhito Funai; Hiroki Mori; Abul Hasan Muhammad Bashar; Teruhisa Kazui
Journal:  Lung Cancer       Date:  2007-06-04       Impact factor: 5.705

7.  Comparison of therapeutic effects of EGFR-tyrosine kinase inhibitors on 19Del and L858R mutations in advanced lung adenocarcinoma and effect on cellular immune function.

Authors:  Juan Zhou; Suqin Ben
Journal:  Thorac Cancer       Date:  2017-12-09       Impact factor: 3.500
  7 in total
  2 in total

1.  Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer.

Authors:  Fernando Franco; Mariano Provencio
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 2.  Surgery after Induction Targeted Therapy and Immunotherapy for Lung Cancer.

Authors:  Toon Allaeys; Lawek Berzenji; Paul E Van Schil
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.